FDA rejects Teva’s high-potency biosimilar of Humira again — After a record run, fewer biotechs are going public— Sarepta shares drop as report says FDA almost rejected under-review gene therapy -- See more on our front page news http://bit.ly/w28kSd #tevapharma #fda #humira #abbvie #biosimilars #ipos #genetherapy #sarepta #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#tevapharma #FdA #humira #abbvie #biosimilars #ipos #genetherapy #sarepta #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
AbbVie's Humira, 5 Pfizer drugs among those with price hikes that exceeded inflation rate — Amgen is sued for concealing $10.7 billion tax bill from investors— In his first year as Johnson & Johnson CEO, Duato scored $13.1M payout -- See more on our front page news http://bit.ly/w28kSd #abbvie #pfizer #humira #drugpricing #inflation #taxes #amgen #legal #jnj #executivepay #ceos #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#abbvie #pfizer #humira #drugpricing #inflation #taxes #amgen #legal #jnj #executivepay #ceos #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Thanks To #Evergreening And Legal Threats, AbbVie Has Earned $114 Billion Since 2016 From A Drug Whose Key Patent Expired Back Then - https://www.techdirt.com/2023/02/10/thanks-to-evergreening-and-legal-threats-abbvie-has-earned-114-billion-since-2016-from-a-drug-whose-key-patent-expired-back-then/#comments the patent system is not fit for purpose... #humira
GSK and Novartis report earnings — Amgen adopts a two-price strategy for first Humira biosimilar, Amjevita — Legislative hurdles anticipated for biopharma in 2023 -- See more on our front page news http://bit.ly/w28kSd #gsk #novartis #earnings #amgen #humira #abbvie #biosimilar #drugpricing #legislation #biopharma #biotech #biotechnology #pharma #pharmanews #cafepharma
#gsk #novartis #earnings #amgen #humira #abbvie #biosimilar #drugpricing #Legislation #biopharma #biotech #biotechnology #pharma #pharmanews #cafepharma
#AbbVie for years delayed competition for its blockbuster drug #Humira, at the expense of patients and taxpayers. The monopoly is about to end.
https://www.nytimes.com/2023/01/28/business/humira-abbvie-monopoly.html
Amgen, navigating 'industry headwinds,' puts 300 commercial jobs on chopping block — The end of the Humira era — Biotech pipeline hosts 163 potential meds for mental illness, with depression dominating -- See more on our front page news http://bit.ly/w28kSd #amgen #layoffs #humira #biosimilars #abbvie #biotech #pipeline #mentalhealth #mentalillness #depression #pharma #pharmanews #biotechnology #biopharma #cafepharma
#amgen #layoffs #humira #biosimilars #abbvie #biotech #pipeline #mentalhealth #mentalillness #depression #pharma #pharmanews #biotechnology #biopharma #cafepharma
This is infuriating!
Check out this article from The New York Times. Because I'm a subscriber, you can read it through this gift link without a subscription.
How a Drug Company Made $114 Billion by Gaming the U.S. Patent System
AbbVie for years delayed competition for its blockbuster drug Humira, at the expense of patients and taxpayers. The monopoly is about to end.
https://www.nytimes.com/2023/01/28/business/humira-abbvie-monopoly.html?unlocked_article_code=LWiIolJGwyuSkEXon803MgC8HThwAueE8wY53i5H4uMmW4k1cZu9z88bY5Ra-dejgp8q8pKlQkKlAUnO333diFLztc80y65ji0_Zs6rSpZNzitl1-EZBZxFzrkPU16JGxdRG6Zj5FvA7TjZ4pTuK1Zo2Vc2LYZkqwONA_7KVvRf4HMbWjGbTDRER5-LYqr-TuomYx99psop6-hnoE07RTUtaZRWMk3aE5RTwnknoqEw6x7rut82x6B2cvnSAM4f0v6LoGmmwlRLN9ex8xO2R2MNfkh-ALrwVoqgliaJNy5PBYaRTTK5hXO3PQUU__P1vKpvSxkgG10r9-OvqNMrZRg&smid=em-share #humira #drugcompanies #bigpharma
#bigpharma #drugcompanies #humira
You'll never guess what happened next...
"The key patent on the best-selling anti-inflammatory medication, used to treat conditions like arthritis, was expiring at the end of the year. Regulators had blessed a rival version of the drug, and more copycats were close behind. The onset of competition seemed likely to push down the medication’s $50,000-a-year list price."
#TNF #RheumatoidArthritis #lupus #PublicHealth #Humira #MonoclonalAntibody
https://www.nytimes.com/2023/01/28/business/humira-abbvie-monopoly.html
#tnf #rheumatoidarthritis #humira #monoclonalantibody #lupus #publichealth
How a #Drug Company Made $114 Billion by Gaming the US #Patent System
Over the past 20 years, #AbbVie and its former parent company increased #Humira’s price about 30 times, most recently by 8% this month over 60% total to over $80,000 a year!
https://nyti.ms/3HAC7Lr #healthcar
#drug #patent #abbvie #humira #healthcar
O AbbVie, you used the patent law
To keep competition at a draw
Your monopoly was sad
But now, it's time to be glad
As competition comes to restore us all
#abbvie #humira #patentsystem #monopoly #ode #poetry
https://www.nytimes.com/2023/01/28/business/humira-abbvie-monopoly.html
#humira #abbvie #monopoly #patentsystem #ode #poetry
Looking past Humira, AbbVie boosts sales forecasts for successor drugs — JPM23, Day 3: Takeda relishing in-person meetups — AstraZeneca and Avillion win approval for new asthma rescue treatment in adults -- See more on our front page news http://bit.ly/w28kSd #jpm2023 #jpm23 #humira #abbvie #takeda #asthma #astrazeneca #fda #biotech #biotechnology #biopharma #pharma #pharmanews #cafepharma
#jpm2023 #jpm23 #humira #abbvie #takeda #Asthma #astrazeneca #FdA #biotech #biotechnology #biopharma #pharma #pharmanews #cafepharma
BioNTech buys UK AI start-up InstaDeep in £562mn deal — JPM23: Gilead, Takeda, Pfizer, Moderna and more —The Big Three PBMs’ 2023 formulary exclusions: observations on insulin, Humira, and biosimilars -- See more on our front page news http://bit.ly/w28kSd #biontech #artificialintelligence #ai #mergersandacquisitions #jpm23 #jpm2023 #pfizer #moderna #takeda #gileadsciences #formulary #humira #pbms #biosimilars #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#biontech #artificialintelligence #ai #mergersandacquisitions #jpm23 #jpm2023 #pfizer #moderna #takeda #gileadsciences #formulary #humira #pbms #biosimilars #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
[pt] enchi um ano e pouco de seringas com restos de linha de bordado! Ainda bem que eu nunca tive medo de agulhas 💉 :needle:
[en] I filled almost a year worth of syringes with scraps of embroidery thread. Good thing I was never afraid of needles. 💉 :needle:
#chrons #humira #humiraJunkies #spoonies #needle #embroidery
#embroidery #needle #spoonies #humirajunkies #humira #chrons
I’m so #itchy from my #eczema 😩 I’m flaring and partly blaming switching health insurances and the delay getting my #Humira approved thanks to my insurance dragging its feet. Thankfully I’m supppsed to get my #Humira #meds next Tuesday and I see my #dermatologist the following week. Until then I may just astral project 😩
#Itchy #eczema #humira #meds #dermatologist
"Switch injection sites each time"
Bold of you to assume I'm gonna remember where I did it last time
@Shyle
Il ya plusieurs traitements pour casser la crise avant des dégâts irréversibles, puis rentrer en rémission. Il te faut vite trouver celui qui marche pour toi, celui à court-terme (typiquement #corticothérapie) et celui à long terme (#Fivasa, #Humira, #Imurel, #Entyvio, #Remicade, ...).
N'aies pas peur si les gastros te proposent plusieurs fois de passer à un traitement plus fort, il faut vraiment rapidement casser la crise.
#Remicade #Entyvio #Imurel #humira #Fivasa #corticothérapie